Sunday, March 16, 2025
HomeIndustriesHealthcare

Healthcare

MIM SureCalc MonteCarlo Selected by Stanford Health Care for Accuray CyberKnife Plan Second Check

MIM Software Inc. announced that MIM SureCalc MonteCarlo has been selected for implementation by Stanford Health Care to perform second check for Accuray CyberKnife...

NephroSant Publishes Real-World Evidence Showing Potential to Improve the Detection of Early Rejection Events with QSant

NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a mission to significantly improve...

FDA Urges Companies to be ‘Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls

The U.S. Food and Drug Administration finalized guidance to help companies prepare to quickly and effectively remove violative products from the market. The guidance...

Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency

Inhibrx, Inc., a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the U.S. Food and Drug Administration,...

AIkido Pharma Reports Improved Manufacturing Process and New United States Patent for Pancreatic Drug

AIkido Pharma Inc. reported an improvement in the manufacturing process for its pancreatic cancer drug, DHA-dFdC, licensed from the University of Texas at Austin....
0FansLike
0FollowersFollow
spot_img

Hot Topics